Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Cerebral Vasospasm in SAH
NCT01346748Phase 4
Key facts
- Status
- Unknown
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Countries
- 1
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Modality
- Small Molecules
- Drugs
- simvastatin
- Conditions
- cerebral vasospasm
01
Overview
Phase 4, randomised, double-blind trial of simvastatin in cerebral vasospasm, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Prevention of cerebral vasospasm secondary to subarachnoid hemorrhage at 6 months. Status: unknown.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Patients aged 18-65 with aneurysmal subarachnoid hemorrhage and Hunt-Hess scale < 3. Excludes those with liver dysfunction, previous statin use, or Hunt-Hess 4-5.
04
Endpoints
Primary
Prevention of cerebral vasospasm secondary to subarachnoid hemorrhage
Beyond the preview
Go deeper on NCT01346748.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346748.